News
Sam Altman, the OpenAI co-founder valued at the center of artificial intelligence's rapid ascent, is preparing a challenge to ...
Altman has also backed the company Longshot Space, which dreams of taking on Musk’s SpaceX with a gigantic gun that shoots ...
2d
GlobalData on MSNLeadership in BCI space ‘far from settled’ despite Neuralink eminence
Neuralink is a dominant force in the BCI space, but the arrival of a new, well-capitalised startup in Merge Labs may change ...
Sam Altman plans to support a brain computer interface startup to rival Neuralink, as OpenAI expands its AI and technology ...
26m
ExtremeTech on MSNGene Therapy Could Let Future Implants Control the Brain Via Ultrasound
One of Sam Altman’s pet projects aims to engineer the brain to better work with brain-computer interface implants.
OpenAI CEO Sam Altman believes that, given all the AI hype from investors and capital expenditures, we're currently in an AI ...
OpenAI faces a "totally screwed up" GPT-5 launch, forcing them to invest trillions in new data centers to fix the issue and regain leadership ...
ChatGPT now reaches 700 million users, but OpenAI’s CEO warns of an AI hype bubble as GPU shortages slow progress toward its ...
4d
PCMag UK on MSNSam Altman Wants His Own Neuralink, But Are You Ready to Merge Your Brain With ChatGPT?
OpenAI's CEO is reportedly raising funds for a brain implant startup that would directly compete with Elon Musk's Neuralink.
During a dinner with a small group of reporters, OpenAI CEO Sam Altman cautioned that investment in AI is moving too fast.
Over dinner, OpenAI CEO’s addressed criticism of GPT-5’s rollout, the AI bubble, brain-computer interfaces, buying Google ...
Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results